Enrico Bernardi
Overview
Explore the profile of Enrico Bernardi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
56
Citations
1501
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Desideri L, Aissani M, Bernardi E, Zinkernagel M, Anguita R
Retina
. 2025 Mar;
PMID: 40068017
Purpose: To determine the incidence, prognostic factors and management of macular edema (ME) associated with silicone oil (SO) tamponade. Methods: This retrospective, comparative, observational study included patients who underwent pars...
2.
Bernardi E, Shah N, Desideri L, Potic J, Roth J, Anguita R
Clin Ophthalmol
. 2025 Feb;
19:629-639.
PMID: 40007877
Purpose: To review the incidence, risk factors, and treatments for cystoid macular edema (CME) following rhegmatogenous retinal detachment (RRD) repair surgery. Methods: A comprehensive literature search was conducted across multiple...
3.
Bernardi E, Desideri L, Artemiev D, Zinkernagel M, Anguita R
BMJ Open Ophthalmol
. 2024 Dec;
9(1.
PMID: 39632092
Purpose: To compare the anatomical and functional outcomes of pars plana vitrectomy (PPV) alone versus PPV with the addition of a scleral buckle in treating inferior rhegmatogenous retinal detachments (RRDs)....
4.
Desideri L, Danilovska T, Bernardi E, Artemiev D, Paschon K, Hayoz M, et al.
Transl Vis Sci Technol
. 2024 Oct;
13(10):21.
PMID: 39392437
Purpose: To identify optical coherence tomography (OCT) biomarkers for macula-off rhegmatogenous retinal detachment (RRD) with artificial intelligence (AI) and to correlate these biomarkers with functional outcomes. Methods: Patients with macula-off...
5.
Desideri L, Sim P, Bernardi E, Paschon K, Roth J, Fung A, et al.
Surv Ophthalmol
. 2024 Sep;
70(1):96-105.
PMID: 39343316
We evaluate the pharmacokinetics, safety, and optimal dosages of intravitreal agents in silicone oil (SO)-filled eyes, addressing challenges in administering such therapies. We assessed the pharmacological properties and safety profiles...
6.
Anguita R, Chou H, Raval V, Bajpai V, Desideri L, Bernardi E, et al.
Semin Ophthalmol
. 2024 Aug;
:1-10.
PMID: 39194361
Background: In the past few decades, the primary management for uveal melanoma has evolved from enucleation to eye-preserving treatments. However, despite achieving a high rate of local tumour control, complications...
7.
Desideri L, Arun K, Doherty G, Bernardi E, Anguita R
J Clin Med
. 2024 May;
13(9).
PMID: 38731235
: The aim of this review paper is to summarise surgical options available for repairing iris defects at the iris-lens plane, focusing on suturing techniques, iridodialysis repair, and prosthetic iris...
8.
Serino F, Bernardi E, Franco F
Rom J Ophthalmol
. 2024 Jan;
67(4):362-367.
PMID: 38239415
To report outcomes in terms of efficacy and safety of patients affected with Primary Open Angle Glaucoma (POAG) and Vitreoretinal Disease, who have undergone Pars Plana Vitrectomy (PPV) and ab-interno...
9.
Desideri L, Artemiev D, Bernardi E, Paschon K, Zandi S, Zinkernagel M, et al.
Expert Opin Investig Drugs
. 2023 Oct;
32(11):1009-1016.
PMID: 37902056
Introduction: Geographic atrophy (GA) is a progressive form of age-related macular degeneration (AMD) that leads to severe visual impairment and central vision loss. Traditional treatment options for GA are limited,...
10.
Camporese G, Bernardi E, Venturin A, Pellizzaro A, Schiavon A, Caneva F, et al.
Front Cardiovasc Med
. 2023 Oct;
10:1273543.
PMID: 37781312
[This corrects the article DOI: 10.3389/fcvm.2022.802183.].